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A B S T R A C T
Selenium participates in the antioxidant defense mainly through a class of selenoproteins, including thioredoxin
reductase. Epigallocatechin-3-gallate (EGCG) is the most abundant and biologically active catechin in green tea.
Depending upon the dose and biological systems, EGCG may function either as an antioxidant or as an inducer
of antioxidant defense via its pro-oxidant action or other unidentiﬁed mechanisms. By manipulating the
selenium status, the present study investigated the interactions of EGCG with antioxidant defense systems
including the thioredoxin system comprising of thioredoxin and thioredoxin reductase, the glutathione system
comprising of glutathione and glutathione reductase coupled with glutaredoxin, and the Nrf2 system. In
selenium-optimal mice, EGCG increased hepatic activities of thioredoxin reductase, glutathione reductase and
glutaredoxin. These eﬀects of EGCG appeared to be not due to overt pro-oxidant action because melatonin, a
powerful antioxidant, did not inﬂuence the increase. However, in selenium-deﬁcient mice, with low basal levels
of thioredoxin reductase 1, the same dose of EGCG did not elevate the above-mentioned enzymes; intriguingly
EGCG in turn activated hepatic Nrf2 response, leading to increased heme oxygenase 1 and NAD(P)H:quinone
oxidoreductase 1 protein levels and thioredoxin activity. Overall, the present work reveals that EGCG is a robust
inducer of the Nrf2 system only in selenium-deﬁcient conditions. Under normal physiological conditions, in
selenium-optimal mice, thioredoxin and glutathione systems serve as the ﬁrst line defense systems against the
stress induced by high doses of EGCG, sparing the activation of the Nrf2 system.
1. Introduction
Green tea is manufactured from the leaves of Camellia sinensis and
is a beverage consumed worldwide. It is characterized by the presence
of large quantities of catechins. Of these catechins, epigallocatechin-3-
gallate (EGCG) constitutes for about 50–75% by weight and is
considered to be the most biologically active catechin [1]. EGCG has
been reported to possess preventive activities against heart diseases,
diabetes and cancer [1]. EGCG acts as an antioxidant or as a pro-
oxidant depending upon the dosage and the cellular redox state [2].
The antioxidant functions of EGCG are associated with its quenching
eﬀect on reactive oxygen species (ROS) and reactive nitrogen species
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(RNS) [3]. Alternatively, due to auto-oxidation of the highly active
hydroxyl groups and concomitant formation of superoxide anion and
hydrogen peroxide [4], EGCG may further modulate antioxidant
defense by activating nuclear factor erythroid 2-related factor 2
(Nrf2) that initiates transcription of a series of cytoprotective genes
[5,6].
The essential trace element selenium (Se) participates in the
antioxidant defense mainly through a class of selenoproteins, which
contain selenocysteine (Sec) that is co-translationally incorporated into
the growing polypeptide from Sec-tRNA[Ser]Sec provided that the
termination codon, UGA, is followed by a Sec insertion sequence
(SECIS) element [7]. In humans, 25 selenoproteins have been found
and of which glutathione peroxidase (GPx) and thioredoxin reductase
(TrxR) are well studied. GPx acts as an antioxidant enzyme by reducing
hydroperoxides and hydrogen peroxide using glutathione (GSH) as a
reducing agent [8]. TrxR catalyzes the reduction of the disulﬁde at the
active site of thioredoxin (Trx) to maintain cellular redox homeostasis.
Trx has a plethora of functions including ROS neutralization and
activation of certain redox-sensitive transcription factors [9].
Inadequate Se intake that occurs in many regions of the world reduces
selenoprotein biosynthesis and disturbs redox homeostasis [10,11].
Notably, selenoprotein biosynthesis was pronouncedly impaired in the
mice fed with Se-free diet for 16 or 22 weeks. In such conditions, the
Nrf2 defense pathway was activated, leading to increased expression of
heme oxygenase 1 (HO1) and NAD(P)H: quinone oxidoreductase 1
(NQO1) [12]. The response of diﬀerent selenoproteins to Se deﬁciency
follows a strict hierarchy and some selenoproteins are synthesized at
the expense of others. For example, low-ranking GPx1 and selenopro-
tein P (SelP) are sensitive to Se deﬁciency, whereas high-ranking TrxR1
is more refractory to Se deﬁciency [13]. Interestingly, knockout of
GPx1 or SelP did not induce hepatic HO1 activity whereas the
inhibition of TrxR by aurothioglucose or 1-chloro-2, 4-dinitrobenzene
upregulated hepatic HO1 activity in mice [14–16]. These results
suggest the importance of TrxR1 in regulating Nrf2 system. TrxR1
reduces the disulﬁde bonds to free cysteine residuals in Kelch-like
ECH-associated protein 1 (Keap1) and keeps them in the reduced state,
which arrests Nrf2 in the cytoplasm [17]. Inactivation of TrxR1 leads to
disulﬁde bond formation in Keap1, and consequently Nrf2 is released
and enters into the nucleus to drive the transcription of many
cytoprotective genes [17]. On the other hand, TrxR1 is also an Nrf2
target gene. Such an intricate interaction between TrxR1 and Nrf2
suggests that TrxR1 is an important regulator of Nrf2 activation [17].
In addition, as a highly conserved housekeeping gene, the core
promoter of TrxR1 can also be regulated by other transcription factors
unrelated to Nrf2, such as octamer binding protein or speciﬁcity
proteins 1 and 3 (Sp1/Sp3) [18].
We and others previously showed that Se and dietary phytochem-
ical sulforaphane could synergistically induce TrxR1 through Nrf2
pathway in vitro [19–21]. This suggests that the interaction of dietary
constituents could signiﬁcantly alter the cellular redox traits. Currently,
three major antioxidant defense systems have been well characterized:
the Trx system comprising of NADPH, Trx and TrxR coupled with
peroxiredoxin (Prx); the GSH system comprising of NADPH, GSH, and
glutathione reductase (GR) coupled with glutaredoxin (Grx); and the
Nrf2 system. In the present study, we investigated the interactions
among these antioxidant defense systems after administration of a
nontoxic, high-dose of EGCG to mice using Se nutritional status as a
perturbator. We demonstrate that, under physiological conditions,
preceding the activation of the Nrf2 system, the Trx and GSH systems
serve as the ﬁrst line defense against EGCG-induced stress in Se-
optimal mice and that EGCG is a potent inducer of the Nrf2 system in
Se-deﬁcient mice.
2. Materials and methods
2.1. Chemicals and drugs
EGCG ( > 99%) puriﬁed from green tea was obtained from Ebeikar
Tea & Extracts Co., Ltd. (Hangzhou, China). Melatonin ( > 98%), GR
(from Escherichia coli), rat TrxR1, β-D-glucuronidase and sulfatase
were all obtained from Sigma (St. Louis. MO, USA). ELISA kits for
interleukin-2, 6 and 10 (IL-2, IL-6 and IL-10) and 4-hydroxynonenal
(4-HNE) were purchased from BD Biosciences (San Jose, CA, USA)
and CUSABIO (Wuhan, China), respectively. ECL Plus reagent and
PVDF membrane were purchased from Bio-Rad Laboratories, Inc.
(USA). The primary antibodies against GPx1/2, Nrf2, HO1, NQO1,
phosphorylated histone 2AX (γ-H2AX) and anti-mouse secondary
antibody as well as anti-rabbit secondary antibodies were obtained
from Santa Cruz (Dallas, TX, USA). The primary antibodies against
Histone H3 and β-actin were purchased from Sigma. The primary
antibodies against p38 and P-p38 were purchased from Cell Signal
Technology, Inc. (USA). TrxR1 primary antibody was kindly provided
by Dr. Gary F. Merrill (Department of Biochemistry and Biophysics,
Oregon State University). Other chemicals were of the highest grade
available.
2.2. Animals and treatments
All protocols involving animal experiments complied with the
guidelines of the Anhui Agricultural University Committee for the
Care and Use of Laboratory Animals. Male Kunming mice (17–19 g)
were purchased from Shanghai SLAC Laboratory Animal Co. Ltd.
(China). The mice were housed in plastic cages with controlled
temperature (25 ± 1 ºC), humidity (50 ± 10%) and 12 h light/dark
cycles. The mice were allowed access to food and water ad libitum.
Paired Se-optimal diet (0.18 mg Se/kg) and Se-deﬁcient diet ( <
0.01 mg Se/kg) were provided by Trophic Animal Feed High-Tech
Co., Ltd. (Nantong, China). After the mice were fed for 5 weeks, 6 mice
were randomly selected from Se-optimal or Se-deﬁciency group, and
were intraperitioneally (i.p.) injected with 70 mg/kg EGCG once daily
for 3 consecutive days and then observed for an additional 12 days. The
remaining fed mice after 6 weeks were i.p. injected with saline or
45 mg/kg EGCG once daily for 7 consecutive days, and then all the
mice were sacriﬁced 24 h after the last treatment.
Additional animal experiment was designed to investigate the
inﬂuence of melatonin on EGCG-meditated antioxidant response in
Se-optimal mice. Male Kunming mice (20–22 g) were fed with Se-
optimal diet and were i.p. injected with saline as control, 45 mg/kg
EGCG, 50 mg/kg melatonin or the combination of EGCG and melato-
nin once daily for 5 consecutive days, and then all mice were sacriﬁced
24 h after the last treatment.
To determine EGCG concentrations following a single dose of
EGCG administration, male Kunming mice (20–22 g) fed with Se-
optimal diet were i.p. injected with EGCG at the dose of 45 mg/kg once
and were sacriﬁced at 0.5, 1, 3 and 24 h, respectively. Mice in the
control group were sacriﬁced at 3 h.
2.3. Biomarker assessments
Serum was centrifuged at 9,000g at 4 °C for 10 min. Serum alanine
aminotransferase (ALT) and aspartate aminotransferase (AST) levels
were measured using commercial kits (Jiancheng Bioengineering
Institute, Nanjing, China). Serum levels of IL-2, IL-6, IL-10 and 4-
HNE were determined using ELISA kits indicated above.
Liver tissues were excised and homogenized in ice-cold 0.15 mM,
pH 7.2 phosphate buﬀer solution (PBS) containing 1 mM EDTA. The
homogenate was obtained by centrifugation (15,000g at 4 °C for
15 min). Protein levels were determined by the Bradford dye-binding
assay with bovine serum albumin as the standard.
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Both GPx and TrxR activities were determined using the Smith and
Levander method with some modiﬁcations [22,23]. For measuring GPx
activity, a stock mixture composed of 6.5 mM EDTA-Na2, 1.3 mM
NaN3, 2.5 mM GSH, 0.5 mM NADPH and 1.7 U/mL GR in 65 mM PBS
(pH 7.4) was freshly prepared and kept at 37 °C. Samples (47 μL) were
mixed with the stock mixture (250 μL) and 3 μL hydrogen peroxide
(H2O2) as a GPx substrate at a ﬁnal concentration of 250 μM. The
changes in absorbance at 340 nm over time were monitored by a
microplate reader at 37 °C. GPx activity was calculated in terms of
μmols of NADPH oxidized/min/mL serum or mg protein. For measur-
ing TrxR activity, a stock mixture composed of 10 mM EDTA-Na2,
5 mM dithio-bis-nitrobenzoic acid, 240 μM NADPH and 0.2 mg/mL
bovine serum albumin in 100 mM PBS (pH 7.0) was freshly prepared
and kept at 37 °C. Then paired samples whose TrxR activities are active
or inhibited by auranoﬁn were prepared as follows: 54 μL sample was
mixed with 6 μL 5% ethanol or 6 μL 5% ethanol containing 1.47 mM
auranoﬁn, at 37 ºC for 10 min, respectively. Reaction was started by
mixing 250 μL the stock solution with 50 μL sample, and the changes
in absorbance at 412 nm over time were monitored by a microplate
reader at 37 °C. TrxR activity was calculated by subtracting the slope
rate of the reaction in the presence of auranoﬁn from the slope rate of
the reaction in the absence of auranoﬁn. The consumption of one
molecule of NADPH reduces of one molecule of dithio-bis-nitrobenzoic
acid and generates two thio-bis-nitrobenzoic acid anions, which have
an extinction coeﬃcient of 13,600 M−1 cm−1 at 412 nm. TrxR activity
was thus presented as µmols of NADPH oxidized/min/mg protein.
Se content was assessed using a 2, 3-diaminonaphthalene-based
ﬂuorescent method [24,25]. Glutathione S-transferase (GST) activity
was assessed using 1-chloro-2, 4-dinitrobenzene (CDNB) and GST
activity was calculated as nmol CDNB conjugate formed/min/mg
protein [26]. Trx activity was determined using the method of
Holmgren and Björnstedt with rat TrxR1 as a Trx reductase, the
activity was presented in terms of µmol of NADPH oxidized/min/mg
protein [27]. GR activity was measured by the method of Carlberg and
Mannervik with oxidized glutathione as a substrate [28], and Grx
activity was determined according to the method of Scian and Atkins
with 2-hydroxyethyl disulﬁde as a model substrate [29]. Both GR and
Grx activities were presented in terms of nmol of NADPH oxidized/
min/mg protein.
To measure plasma EGCG, 100 μL plasma was transferred into an
Eppendorf tube containing 20 μL ascorbate-EDTA solution (0.4 M
NaH2PO4 buﬀer containing 20% ascorbic acid-0.1% EDTA, pH 3.6)
and then 10 μL of a mixture of β-D-glucuronidase (250 U) and sulfatase
(1 U) was added. The mixture was incubated at 37 °C for 45 min.
Following the addition of 1 mL of ethyl acetate, the mixture was
vortexed for 3 min and centrifuged at 13,000g for 10 min at 4 °C. The
upper organic phase was mixed with 10 μL of 0.2% ascorbic acid and
then was dried by vacuum centrifugation. The dried solid was dissolved
in 100 μL of 10% methyl alcohol aqueous solution and centrifuged at
17,000g for 15 min at 4 °C. The resultant supernatant (5 μL) was
analyzed using ultra-high performance liquid chromatography (UPLC)-
triple quadrupole mass spectrometer (QQQ-MS/MS). Separation was
achieved by a Hypersil GOLD column (particle size 1.9 mm; column
size 50×2.1 mm) with a guard column (particle size 3 mm; column size
10×2.1 mm) at 35 °C. The mobile phase consisted of (A) 0.05%
aqueous formic acid and (B) methanol. The gradient of solvent B was
as follows: 0–1 min, 10%; 1–7 min, from 10% to 30%; 7–7.5 min, from
30% to 70%; then kept at 70% to 8 min; 8–8.5 min, from 70% to 10%;
then kept at 10% to 10.5 min. The elution rate was 0.3 mL/min. Mass
spectra were acquired simultaneously using electrospray ionization in
the negative ionization mode over the range of m/z 100–1000. The dry
gas was set to 6 L/min at 325 °C with a nebulizer pressure of 45 psi.
The MRM mode of QQQ-MS/MS was used to detect the target
compounds by selected product ions from the parent ions (EGCG/
GCG, 457→169). The data of UPLC-QQQ-MS/MS were analyzed by
Agilent MassHunter Qualitative Analysis software. To measure hepatic
EGCG levels, 0.2g liver was homogenized with 1 mL of the ascorbate-
EDTA solution and 500 μL homogenate was incubated with 20 μL of
the mixture of β-D-glucuronidase and sulfatase at 37 °C for 45 min.
Then 200 μL of ethanol was added to precipitate the tissue. Following
the addition of 500 μL of methylene chloride and suﬃcient votex, the
mixture was centrifuged at 16,000g for 5 min at 4 °C. The upper
aqueous phase was extracted with ethyl acetate and the subsequent
procedures were carried out in a same manner as the plasma samples.
2.4. RNA isolation, cDNA synthesis and Real-time PCR
Total RNA from the liver was isolated with Trizol reagent according
to the manufacturer's protocol (Takara Biotechnology, Dalian, China),
and cDNA synthesis was carried out with reverse transcriptase contain-
ing 100 ng of total RNA, oligo dT primer, and PrimeScript RT Enzyme
Mix according to the manufacturer's instructions (RT-for-PCR kit,
Takara Biotechnology). Real-time PCR was performed with a CFX
System (Bio-Rad) according to the manufacturer's instructions (Takara
Biotechnology). GAPDH or ribosomal protein S6 (Rps6) was selected
as a housekeeping gene for normalizing all the gene expressions.
Primers used for PCR reactions were designed using available gene
sequences as shown in Table 1.
2.5. Preparation of nuclear fractions
The preparation of nuclear fraction was carried out according to the
method of Carmona-Ramíreza et al. [30]. In brief, liver tissues were
washed once with cold PBS and then were lysed on ice with 10-fold
volume of cold isotonic buﬀer A plus protease inhibitor cocktail
(Sigma) at a concentration of 1 μg/mL for 10 min. After centrifugation
at 500g for 5 min, the nuclear pellets were washed for 10 min with cold
buﬀer B and then resuspended in hypertonic cold buﬀer C plus the
protease inhibitor cocktail. Nuclear fractions without cytosol contami-
nant were validated using trypan blue dye exclusion assay.
Table 1
Primer sequences for RT-PCR.
Genes Direction Sequences Gene Bank
HO1 Forward 5′-TCAGAAGGGTCAGGTGTCCAGA-3′ NM_010442.2
Reverse 5′-GCATAGACTGGGTTCTGCTTGTT-3′
NQO1 Forward 5′-GGCGAGAAGAGCCCTGATTG-3′ NM_008706.5
Reverse 5′-GTTCATAGCATAGAGGTCAGATTCG-3′
p21 Forward 5′-GACTTCTCCCATTTCTTAGTAGCAG-3′ NM_007669.4
Reverse 5′-TGACACCCACGGTATTCAACAC-3′
TrxR1 Forward 5′-ACCTGGGCATCCCTGGAGAC-3′ BC037643.1
Reverse 5′-GCACCATTACAGTGACGTCTAAGC-3′
GAPDH Forward 5′-CTTTGGCATTGTGGAAGGGCTC-3′ AY618199.1
Reverse 5′-GCAGGGATGATGTTCTGGGCAG-3′
Rps6 Forward 5′-ACTACTGTGCCTCGTCGGTTGG-3′ BC092050.1
Reverse 5′-TGCTTTGGTCCTGGGCTTCTTAC-3′
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2.6. Western blot analysis
The concentrations of total protein extracted with the RIPA reagent
were determined by the BCA protein assay kit (Beyotime
Biotechnology, Shanghai, China). Protein extracts were boiled at
95 °C for 10 min in loading buﬀer, and then loaded onto 10% SDS-
PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) for
protein separation. Proteins in the gel were transferred to a PVDF
membrane. The membrane was blocked with 5% non-fat dried milk in
tris buﬀered saline with 0.05% Tween 20 (TBS-T) for 2 h at room
temperature (RT), and then incubated with speciﬁc primary antibodies
diluted in TBS-T by 200 to 5,000 folds overnight at 4 °C. The
membranes were washed four times, each for 10 min with TBS-T and
then were incubated with secondary antibody diluted in TBS-T by
2500- or 5000-fold for 1 h at RT. After washing for four times with
TBS-T, antibody bindings were detected using the ChemiDoc XRS+
detection system (ECL, Bio-Rad), and the corresponding bands were
quantiﬁed by densitometry with the Quantity One® Image Analyzer
software program (Bio-Rad).
2.7. Statistical analysis
The data are presented as means ± SEM. All statistical analyses
were performed using GraphPad Software (Prism version 5, San Diego,
California). The signiﬁcances were examined by one-way analysis of
variance (ANOVA) post hoc Tukey or Dunnett test, or two-way ANOVA
post hoc Bonferroni test, as appropriate. Log-rank test was used for
survival comparison. A p-value less than 0.05 was considered statisti-
cally signiﬁcant.
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Fig. 1. Biomarkers of Se status. Mice were fed with Se-optimal or Se-deﬁcient diet for 7 weeks. During the last 7 days, mice were i.p. injected with saline or 45 mg/kg EGCG once
daily. (A) Serum GPx activity. (B) Hepatic Se levers. (C) Hepatic GPx activity. (D) and (D′) Hepatic GPx1 protein. (E) Hepatic GPx1 mRNA. Data are presented as means ± SEM (n=6).
**p < 0.01 and ***p < 0.001 vs. control.
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3. Results
3.1. Selenium status
Dietary Se deﬁciency can result in signiﬁcant decrease of Se content
and selenoenzyme activities, particularly GPx1 activity in the liver
[31,32]. In the present study, the levels of serum and hepatic GPx
activity (Fig. 1A,C), hepatic GPx1 protein and mRNA (Fig. 1D,D′,E) as
well as hepatic Se (Fig. 1B) signiﬁcantly decreased in the mice fed with
Se-deﬁcient diet, indicating that the Se deﬁciency model had been
successfully established. EGCG decreased the expression of hepatic
GPx1 protein but increased the expression of hepatic GPx1 mRNA in
the Se-optimal mice (Fig. 1D,D′,E). However, EGCG treatment did not
aﬀect the levels of serum or hepatic GPx activity or hepatic Se levels,
irrespective of Se status (Fig. 1).
3.2. Dynamic change of plasma and hepatic EGCG levels
Following a single i.p. injection of EGCG (45 mg/kg), the plasma
and hepatic EGCG levels were 5.7 μM and 3.6 µg/g (8 nmol/g),
respectively, at 0.5 h. Then the levels decreased time-dependently over
24 h (Fig. 2).
3.3. EGCG enhances hepatic TrxR, GR and Grx activities only in
selenium-optimal mice
EGCG signiﬁcantly induced the mRNA and protein levels of hepatic
TrxR1 in the Se-optimal mice (Fig. 3A, B and B′), leading to the
augment of TrxR activity (Fig. 3C). As expected, Se deﬁciency resulted
in a signiﬁcant decrease of hepatic TrxR1 mRNA and protein levels as
well as TrxR activity (Fig. 3A–C). Notably, EGCG signiﬁcantly in-
creased hepatic TrxR activity through inducing TrxR1 mRNA and
protein (Fig. 3A–C) as well as hepatic GR and Grx activities in the Se-
optimal mice (Fig. 3D and E). However, Se deﬁciency abolished the
induction eﬀects of EGCG on these enzymes (Fig. 3A–E).
3.4. Melatonin does not inﬂuence the induction of hepatic TrxR, GR
and Grx activities by EGCG in selenium-optimal mice
To investigate whether EGCG-induced increases of hepatic TrxR,
GR and Grx activities in Se-optimal mice are associated with overt pro-
oxidant eﬀects of EGCG, melatonin that can attenuate EGCG-evoked
hepatotoxicity [33] was employed. The eﬀects of EGCG on hepatic
TrxR1 protein and TrxR, GR and Grx activities in Se-optimal mice seen
above were herein recapitulated (Fig. 4A-D). Melatonin did not
inﬂuence the eﬀects of EGCG on either hepatic TrxR1 protein
(Fig. 4A,A′) or TrxR and Grx activities (Fig. 4B,D). Melatonin even
modestly enhanced the induction of hepatic GR activity by EGCG, most
likely due to an additive eﬀect, since melatonin itself signiﬁcantly
raised hepatic GR activity (Fig. 4C). These results suggest that the
induction of key enzymes in the Trx and GSH systems by EGCG
probably involves only mild rather than overt pro-oxidant action of
EGCG.
3.5. Selenium deﬁciency promotes the elevation of Nrf2 response
caused by EGCG
EGCG slightly but not signiﬁcantly increased the nuclear Nrf2
protein levels in the liver (Fig. 5A) and signiﬁcantly increased hepatic
mRNA levels of NQO1 (Fig. 5B). However, EGCG did not signiﬁcantly
activate hepatic Nrf2 responses since HO1 mRNA levels, HO1 and
NQO1 protein levels, and Trx and GST activities were not signiﬁcantly
increased (Fig. 5C-F). Although Se deﬁciency had a tendency of
increasing nucleus Nrf2 protein levels (Fig. 5A), neither mRNA levels
nor protein levels of hepatic NQO1 and HO1 were signiﬁcantly
increased in response to Se deﬁciency (Fig. 5B-D). However, hepatic
GST activity was signiﬁcantly enhanced in Se deﬁcient mice (Fig. 5F),
presumably associated with the non-signiﬁcant increase of Nrf2 protein
in the nucleus. In Se-deﬁcient mice, EGCG signiﬁcantly increased
hepatic Nrf2 protein levels in the nucleus and consequently caused a
signiﬁcant induction of both mRNA and protein levels of HO1 and
NQO1 as well as a signiﬁcant increase of Trx activity (Fig. 5). Overall,
both EGCG and Se deﬁciency alone appeared to trigger a modest Nrf2
response as evidenced by NQO1 mRNA induction and GST activity
elevation, respectively. Only in Se-deﬁcient conditions, EGCG caused a
robust Nrf2 response. Such a unique Nrf2 response appeared to be
associated with phosphorylation of p38 mitogen-activated protein
kinase, which was increased by 2.2-fold (p < 0.01) only in Se-deﬁcient
mice when treated with EGCG (Supplementary Fig. 1).
Our previous studies have shown that high-dose EGCG-evoked
hepatotoxicity is associated with hepatic Nrf2 activation, whereas
EGCG at a non-toxic high dose (45 mg/kg, i.p.) for 5–7 days in
Kunming mice, which are also used herein, did not generate a
comprehensive Nrf2 response in the liver of Se-adequate mice
[33,34]. Therefore, we next investigated whether the robust Nrf2
response as seen in the Se-deﬁcient mice was associated with the
EGCG-triggered hepatotoxicity.
3.6. Selenium deﬁciency does not enhance EGCG toxicity
High-dose EGCG could generate excessive amounts of ROS, which
might trigger hepatotoxicity and even lethality [35,36]. In the present
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study, the administration of EGCG (45 mg/kg, i.p.) once daily for 7
days to the Se-optimal mice neither aﬀected body weight (Fig. 6A) nor
caused hepatotoxicity as indicated by the normal serum levels of ALT,
AST and 4-HNE (Table 2), as well as hepatic γ-H2AX protein (Fig. 6C)
whose expression has been demonstrated to be dramatically increased
during the EGCG-triggered liver injury [33–36]. The EGCG treatment
actually decreased the inﬂammation as evidenced by the lower levels of
serum IL-2 and IL-10 (Table 2). Although no toxic eﬀects were
observed, the EGCG dose used was likely the maximum non-toxic
dose, because of the modest but signiﬁcant increase of hepatic p21
mRNA (Fig. 6B). In this context, it is worth noting that we previously
found that p21 mRNA levels were increased over one order of
magnitude by EGCG at a dose triggering hepatotoxicity (55 mg/kg,
i.p., once daily for 5 consecutive days in Kunming mice, the same
mouse strain as used herein, our unpublished data). If Se deﬁciency
enhances EGCG toxicity, the maximum non-toxic dose of EGCG is
expected to decrease in the Se-deﬁcient mice. However, the Se-deﬁcient
mice well tolerated to the maximum non-toxic dose of EGCG (45 mg/
kg) indentiﬁed in the Se-optimal mice as reﬂected in body weight
(Fig. 6A) and hepatic γ-H2AX protein (Fig. 6C), serum ALT and AST
activities, and 4-HNE levels (Table 2). Moreover, Se deﬁciency did not
interfere with the beneﬁcial eﬀect of EGCG on inﬂammatory markers
(Table 2) and even abolished the elevation of p21 mRNA levels
(Fig. 6B). These results indicate that Se deﬁciency does not enhance
EGCG toxicity under the experimental conditions used. Our present
results suggest that the robust Nrf2 response to EGCG in the Se-
deﬁcient mice (Fig. 5) was not related to the EGCG-evoked hepato-
toxicity. It is possible that the activation of the Nrf2 cytoprotective
enzymes compensated for the deﬁcit in antioxidant defense caused by
Se deﬁciency. Further support for the idea that Se deﬁciency does not
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Fig. 3. Inﬂuence of EGCG on hepatic TrxR1, GR and Grx. Mice were fed with Se-optimal or Se-deﬁcient diet for 7 weeks. During the last 7 days, mice were i.p. injected with
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enhance the toxicity of EGCG was obtained from another experiment
using lethal doses of EGCG. Administration of EGCG (70 mg/kg, i.p.)
to mice, once daily for 3 days, resulted in the same (50%) mortality in
the Se-optimal and Se-deﬁcient mice (Fig. 6D). Moreover, the survival
proﬁles of the two groups showed no signiﬁcant diﬀerences.
4. Discussion
Trx and GSH systems are the two well-documented NADPH-
dependent disulﬁde reduction pathways that are essential for main-
taining redox homeostasis. In response to an oxidative stress, the Nrf2
pathway is also known to be activated to participate in the maintenance
of redox homeostasis. The present study revealed a Se status-depen-
dent switch of hepatic defense pathways in response to EGCG. In Se-
optimal mice, EGCG simultaneously enhanced hepatic Trx and GSH
systems, whereas in Se-deﬁcient mice, EGCG did not induce these two
systems and became a more eﬃcient Nrf2 activator in the liver.
Chemically, EGCG has a strong ROS and RNS scavenging capacity
[37]. In addition, EGCG has been shown to increase the activities of
Mn-SOD and total SOD, catalase and GR in isolated human neutrophils
[38] and to upregulate the expression of Prx6 in murine and human
submandibular gland cells [39]. Moreover, green tea can signiﬁcantly
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Fig. 4. Inﬂuence of melatonin on EGCG-mediated increase of hepatic TrxR, GR and Grx activities. Se-optimal mice were i.p. injected with saline, 45 mg/kg EGCG, 50 mg/
kg melatonin or the combination of EGCG and melatonin once daily for 5 consecutive days. (A) and (A′) Hepatic TrxR1 protein. (B) Hepatic TrxR activity. (C) Hepatic GR activity. (D)
Hepatic Grx activity. Data are presented as means ± SEM (n=6). *p < 0.05, **p < 0.01 and ***p < 0.001 vs. Control.
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increase intestinal, pulmonary and hepatic GPx and catalase activities
in mice [40]. Therefore, both the direct ROS/RNS scavenging capacity
and the induction of antioxidant enzymes are viewed as antioxidant
mechanisms of green tea polyphenols, in particular the well-studied
EGCG. Our present study is the ﬁrst to demonstrate that EGCG can
increase hepatic TrxR, GR and Grx activities simultaneously in mice.
The Trx and GSH systems provide electrons to ribonucleotide reduc-
tase for DNA replication and jointly support a wide range of reductive
pathways and protect cells against the oxidative damage. They also
serve as a backup system for each other [41]. Thus, only when both
systems are inhibited, pronounced tissue damages or cell death would
occur. Several lines of observations are consistent with this concept: 1)
Buthionine sulfoximine (BSO) (a GSH biosynthesis inhibitor) and
auranoﬁn (a potent TrxR inhibitor), when used together, signiﬁcantly
sensitized the response of cancer cells to cytotoxic drugs [42]; 2) The
combination of BSO and arsenic trioxide (a TrxR inhibitor) or BSO and
nedaplatin (a TrxR inhibitor) synergistically killed cancer cells in vitro
or in vivo, respectively [43,44]; 3) Co-treatment of BSO with either
ifosfamide or cyclophosphamide (which inactivates TrxR) induced
much more severe acute renal failure or heart injury in mice than a
single agent alone [45,46]. We propose that the EGCG-induced
enhancement of hepatic Trx and GSH systems and their concerted
actions is an important mechanism by which EGCG exerts antioxidant
eﬀect.
Among the investigated three enzymes whose activities were
increased by EGCG, only TrxR1 gene is a well-elucidated Nrf2 target
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gene [47]. Melatonin, which is a free radical scavenger and a broad-
spectrum antioxidant [48–50], can eﬀectively alleviate high-dose
EGCG-triggered oxidative stress and suppress EGCG-induced Nrf2
activation [33,34]. The present result, showing that melatonin did not
inﬂuence the induction of TrxR1 by EGCG, suggests that overt pro-
oxidant action of EGCG is not involved in the EGCG-induced increase
of TrxR1. Previous studies demonstrate that inhibition of TrxR1 elicits
Nrf2 response [14–16]. TrxR1 can act as a potent regulator and
gatekeeper of Nrf2 [17,51]. The mechanisms by which TrxR1 is
induced by EGCG are unclear. One possibility is that a mild TrxR1
inhibition by EGCG [52,53] can trigger TrxR1 synthesis through a mild
and transient activation of Nrf2, which increases the transcription of
TrxR1 [17]. In this scenario, the induced TrxR1 in turn plays a role as a
gatekeeper to close the door for overt Nrf2 activation. Another
possibility is that EGCG activates the forkhead box class O (FoxO)
transcription factors [54]. Upon translocation into the nucleus, FoxO
stimulates the transcription of genes coding for a myriad of antioxidant
proteins, including members of the superoxide dismutase, Prx, Trx and
TrxR families [55,56]. This mechanism may explain why EGCG could
increase many antioxidant enzyme activities. Whether FoxOs partici-
pate in the EGCG-induced increase of TrxR, GR or Grx activity requires
further investigation. Emerging evidence has shown that S-glutathio-
nylation of Keap1 leads to Nrf2 activation [57,58], and this suggests
that Grx in conjunction with GSH system can participate in attenuating
Nrf2 activation. Based on the above discussion, we propose that, in Se-
optimal conditions, high basal TrxR1 and its induction by EGCG as well
as the related increase in GR and Grx activities limit Nrf2 activation;
whereas in Se-deﬁcient conditions, low basal TrxR1 and its mute
response to EGCG as well as the related lack of induction of GR and Grx
promote Nrf2 activation. The interactions among these enzyme sys-
tems are depicted in Fig. 7.
In vitro experiments have shown that many Nrf2 inducers upregu-
late TrxR1 mRNA under either Se-deﬁcient or Se-replete conditions
[19,59–61]. However, how Se status inﬂuences Nrf2 inducer-triggered
upregulation of TrxR1 mRNA remains unclear. Some studies found
that TrxR1 mRNA was more eﬃciently induced in Se-replete condi-
tions compared to Se-deﬁcient conditions [19,60], whereas the oppo-
site result was also reported [61]. The present study shows that EGCG
induces gene expression of hepatic TrxR1 only in Se-adequate but not
in Se-deﬁcient mice. The discrepancy between in vitro and in vivo Se-
deﬁcient conditions on TrxR1 mRNA regulated by Nrf2 inducer may be
related to the diﬀerent inﬂuences of Se levels on basal TrxR1 mRNA in
vitro and in vivo. Se status did not aﬀect basal TrxR1 mRNA levels in
vitro [19,60,61]. However, we found that Se deﬁciency signiﬁcantly
reduced basal TrxR1 mRNA levels in vivo (Fig. 3A), which is similar to
the observation reported by others [62]. Under Se-deﬁcient conditions,
biosynthesis of TrxR1 is impaired even if EGCG induces TrxR1 mRNA.
We have shown in this study that EGCG did not aﬀect hepatic GPx
activity irrespective of Se status (Fig. 1C). Since GPx1 is an important
member of GSH system and is one of the most abundant selenoen-
zymes in the liver, we also investigated the inﬂuence of EGCG on GPx1
expression. We found that in the Se-optimal mice, EGCG decreased the
expression of hepatic GPx1 protein (Fig. 1D, D′) but increased the
expression of hepatic GPx1 mRNA (Fig. 1E). The EGCG-induced
elevation of hepatic GPx1 mRNA might be associated with the
activation of p53 [63,64]. The activation of p53 by EGCG is suggested
by the increase of p21 in the Se-adequate mice (Fig. 6B). The lower
expression of GPx1 protein may be due to Se sequestration by highly
increased TrxR1 protein [65–69], since TrxR1 is at the top of
selenoprotein hierarchy while GPx1 is at the bottom [13]. GPx family
comprises 8 members, GPx1-4 and 6 are selenoprotein and GPx5, 7
and 8 are not [70]. EGCG can induce the expression of hepatic GPx2, 3,
5 and 7 mRNA [36]. Thus, reduced hepatic GPx1 protein levels caused
by EGCG may not aﬀect total activity of hepatic GPx.
In this study, we used a Se deﬁciency diet as a tool to study the
interactions among the anti-oxidative defense enzyme systems. The
serum GPx activity, a commonly used biomarker for Se status, in the
mice after Se deprivation in the present study was approximately 14%
of Se-adequate mice. This is similar to conditions produced by using a
marginal Se deﬁcient diet (50% of the Se-adequate levels) [71]. Overt
Se deﬁciency would markedly induce hepatic Nrf2 response, as was
reported previously [12]. Typical Nrf2 response in the liver of the mice
post Se deprivation in the present study was not observed. Thus, the
present results were probably obtained from an intermediate Se status
between suboptimal Se levels and overt Se deﬁciency. EGCG-induced
Nrf2 response in humans with suboptimal Se levels may or may not be
as strong as seen in this study. However, the presently observed
Table 2
Serum biomarkers associated with hepatic damage and inflammation.
Serum
parameters
Control EGCG Se deﬁciency Se deﬁciency/
EGCG
ALT (U/mL) 31.3 ± 7.6 50.9 ± 11.7 28.5 ± 2.4 30.6 ± 4.2
AST (U/mL) 22.2 ± 3.3 21.8 ± 3.0 17.1 ± 2.6 18.4 ± 1.5
IL-2 (pg/mL) 94.7 ± 12.7 37.0 ± 7.3** 52.8 ± 17.3* 29.4 ± 1.7**
IL-10 (ng/mL) 3.4 ± 0.3 1.5 ± 0.2** 2.7 ± 0.6 1.2 ± 0.1***
IL-6 (ng/mL) 0.6 ± 0.1 0.9 ± 0.1 0.7 ± 0.1 0.9 ± 0.1
4-HNE (ng/mL) 4.6 ± 0.3 4.5 ± 0.4 4.4 ± 0.8 4.4 ± 0.2
Mice were fed with Se-optimal or Se-deficient diet for 7 weeks. During the last 7 days,
mice were i.p. injected with saline or 45 mg/kg EGCG once daily. Data are presented as
means ± SEM (n=6).
* p < 0.05 vs. control.
** p < 0.01 vs. control.
*** p < 0.001 vs. control.
Fig. 7. A Se status-dependent diverged regulation of cellular defense pathways in response to EGCG. Formation of disulﬁde bonds and/or S-glutathionylation in Keap1
activates Nrf2. In Se-optimal condition, high basal TrxR1 and its induction by EGCG as well as related increase in GR and Grx activities limit Nrf2 induction by EGCG (left panel). In Se-
deﬁcient condition, low basal TrxR1 and its mute response to EGCG as well as the lack of responses of GR and Grx to EGCG promote Nrf2 activation (right panel).
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induction of hepatic TrxR1, GR and Grx by EGCG is expected to
similarly occur in Se-adequate humans. Peak plasma concentrations of
EGCG in mice and humans following pharmacological oral doses have
been reported to be 2–9 μM and 7.5 μM, respectively [72]. In the
present study, peak plasma EGCG concentration of mice subjected to
single i.p. injection of EGCG (45 mg/kg) was 5.7 μM (Fig. 2A), thus the
dose of EGCG employed in this study, although much higher than that
resulted from consumption of tea beverages, is similar to the con-
sumption of green tea extract-based dietary supplements (for weight
loss), in which EGCG is a major ingredient. Adverse reactions, mainly
hepatotoxicity, owing to copious consumption of green tea extracts by
some individuals have been observed, but the percentage is rather low
[73,74]. It is likely that presently observed responses of anti-oxidative
defense systems serve as the protective mechanisms.
Based on the present results, we conclude that in Se suﬃciency, the
higher basal levels of TrxR1 and the induction of TrxR1, GR and Grx by
EGCG would spare Nrf2 from activation by EGCG; whereas in Se
deﬁciency, the Nrf2 system is robustly activated due to the lower basal
levels of TrxR1 and the lack of TrxR1, GR and Grx induction by EGCG.
Our study is the ﬁrst demonstration of the interactions of these anti-
oxidative defense enzymes in response to the stress of a dietary
chemical, EGCG, in animals.
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